Home Health Hindustan Syringes launches Dispojekt to scale back needle stick accidents

Hindustan Syringes launches Dispojekt to scale back needle stick accidents

0
Hindustan Syringes launches Dispojekt to scale back needle stick accidents

[ad_1]

Syringes and needles maker put trade margin cap of 75% after NPPA nudge

The corporate is aiming to initially produce 200 million syringes and needles every year, for which we have now invested roughly Rs 70 crore within the first section


Hindustan Syringes and Medical Units (HMD), one of many main producers of disposable and auto-disable syringes, on Thursday introduced the launch of Dispojekt, an indigenous single-use security syringe to scale back cases of needle stick accidents. 


A needle stick harm (NSI) is an unintentional skin-penetrating stab wound from a hollow-bore needle containing one other particular person’s blood or physique fluid.


It may result in the transmission of blood-borne ailments like Hepatitis B, C, and HIV amongst healthcare personnel.


“HDM is eyeing a 60-70 per cent market share within the subsequent three years within the disposable syringes section in India, which is estimated to be over 5 billion items per 12 months and 5 to six billion needles,” the corporate stated in a press release. 




Sohail Nath, govt director of HMD stated the corporate is aiming to initially produce 200 million syringes and needles every year, for which we have now invested roughly Rs 70 crore within the first section.


“The capability will additional be elevated to 300 million items every year by investing one other Rs 10 to fifteen crore within the second section,” he added. 


Addressing the fee points, Nath stated Dispojekt security needle syringes have been designed to be reasonably priced for the growing world, together with India, and are almost half the price of single-use syringes within the US and Europe.


On managing the stock and distribution of the newly launched syringe, Nath stated HMD has a nationwide distribution community of over 9,500 sellers and over 60 contractual inventory factors in key metropolitan, Tier-I, and Tier-II cities.


“That is assisted by their devoted gross sales pressure, making certain that provide chain administration is uninterrupted as has been the case for its Dispovan syringes with fast supply and quick time period fast supply and switch round cycle,” he stated.


Citing a examine from the Worldwide Journal of Group Medication and Public Well being, the corporate claimed the general prevalence of NSI in India in 2021 was 20.1 per cent.


NSI’s prevalence amongst nurses was the very best at 31.3 per cent, adopted by technicians at 37.5 per cent, ward boys and different employees at 15 per cent, and sweepers of private and non-private hospitals at 15.6 per cent.

 


“With Dispojekt security syringes, HMD goals to scale back the prevalence of unintentional NSI amongst well being employees, discount of an infection management price and that of disposal and coaching, providing a long-term constructive monetary affect on the healthcare sector,” the corporate added. 

First Printed: Mar 07 2024 | 7:28 PM IST

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here